"Hope, like the gleaming taper’s light, Adorns and cheers our way;
And still, as darker grows the night, Emits a brighter ray."

— Oliver Goldsmith (1730?–1774)




CML Medical Journal Articles

  • Home
  • Gleevec Resource Center
  • Back to CML Medical Journal Articles


      Journal Articles About CML

    CANCER

  • Granulocyte-colony stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia
    June 15, 2004

  • Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase
    June 1, 2004

  • Imatinib mesylate causes hypopigmentation in the skin [scroll down]
    June 1, 2004

  • The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase
    Jan. 1, 2004

  • Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase
    Dec. 15, 2003

  • Imatinib mesylate causes hypopigmentation in the skin
    Dec. 1, 2003

  • Results of decitabine (5-aza-2' deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
    Cancer, Aug. 1, 2003

  • Chronic myelogenous leukemia: a review and update of therapeutic strategies
    Cancer, Aug. 1, 2003

  • Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications
    Cancer, July 1, 2003

  • Severe Periorbital Edema Secondary to STI571 (Gleevec)
    Cancer, Aug. 15, 2002 / Volume 95 / Number 4

  • Chronic Myelogenous Leukemia in T Cell Lymphoid Blastic Phase Achieving Durable Complete Cytogenetic and Molecular Remission with Imatinib Mesylate (STI571; Gleevec) Therapy
    CANCER June 1, 2002 / Volume 94 / Number 11





  • Give me a holler





    Today Is:





    © 2000-2004 CMLSupport.com Inc. All rights reserved.

    These contents may not be reproduced in whole or in part in any medium without the express written permission of CMLSupport.com Inc. This site is best viewed with Internet Explorer.